Fifth Third Bancorp Ionis Pharmaceuticals Inc Transaction History

Fifth Third Bancorp

$28.3 Billion
Q2 2025

A detailed history of Fifth Third Bancorp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 7,598 shares of IONS stock, worth $323,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,598

Previous 9,989 23.94%

Holding current value

$323,294

Previous $301,000 0.33%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$25.51 - $40.0 $60,994 - $95,640	-2,391 Reduced 23.94%	7,598 $300,000
Q1 2025 Apr 15, 2025	BUY	$30.17 - $34.97 $13,817 - $16,016	458 Added 4.81%	9,989 $301,000
Q4 2024 Jan 21, 2025	SELL	$33.73 - $40.36 $1,382 - $1,654	-41 Reduced 0.43%	9,531 $333,000
Q3 2024 Oct 17, 2024	BUY	$40.06 - $51.86 $4,406 - $5,704	110 Added 1.16%	9,572 $383,000
Q2 2024 Jul 22, 2024	SELL	$36.45 - $47.7 $6,232 - $8,156	-171 Reduced 1.78%	9,462 $450,000
Q1 2024 Apr 23, 2024	BUY	$42.03 - $53.55 $14,752 - $18,796	351 Added 3.78%	9,633 $417,000
Q4 2023 Jan 19, 2024	BUY	$43.39 - $51.63 $294,270 - $350,154	6,782 Added 271.28%	9,282 $469,000
Q2 2023 Jul 25, 2023	SELL	$34.73 - $43.33 $17,365 - $21,665	-500 Reduced 16.67%	2,500 $102,000
Q1 2023 Apr 24, 2023	BUY	$33.58 - $41.2 $16,790 - $20,600	500 Added 20.0%	3,000 $107,000
Q2 2022 Aug 04, 2022	SELL	$31.71 - $43.0 $6,785 - $9,202	-214 Reduced 7.89%	2,500 $93,000
Q1 2022 Apr 19, 2022	BUY	$29.88 - $37.04 $2,629 - $3,259	88 Added 3.35%	2,714 $101,000
Q3 2021 Oct 15, 2021	BUY	$33.54 - $40.55 $2,414 - $2,919	72 Added 2.82%	2,626 $88,000
Q2 2021 Aug 06, 2021	SELL	$34.54 - $47.25 $241,918 - $330,939	-7,004 Reduced 73.28%	2,554 $102,000
Q1 2021 May 07, 2021	SELL	$42.51 - $63.78 $4,251 - $6,378	-100 Reduced 1.04%	9,558 $430,000
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $63,601 - $84,619	-1,404 Reduced 12.69%	9,658 $546,000
Q3 2020 Nov 09, 2020	SELL	$47.45 - $62.95 $5,978 - $7,931	-126 Reduced 1.13%	11,062 $525,000
Q1 2020 May 05, 2020	BUY	$41.6 - $63.4 $33,529 - $51,100	806 Added 7.76%	11,188 $529,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $166,935 - $202,337	3,100 Added 42.57%	10,382 $627,000
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $8,977 - $10,966	-152 Reduced 2.04%	7,282 $436,000
Q2 2019 Aug 07, 2019	BUY	$62.09 - $86.14 $27,319 - $37,901	440 Added 6.29%	7,434 $478,000
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $4,074 - $6,250	-77 Reduced 1.09%	6,994 $568,000
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $2,038 - $2,798	-47 Reduced 0.66%	7,071 $382,000
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $22,469 - $28,138	-524 Reduced 6.86%	7,118 $367,000
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $23,142 - $28,949	571 Added 8.08%	7,642 $318,000
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $303,358 - $378,854	6,882 Added 3641.27%	7,071 $312,000
Q2 2017 Aug 11, 2017	BUY	N/A	189	189 $10,000

Others Institutions Holding IONS

# of Institutions

404

Shares Held

145M

Call Options Held

916K

Put Options Held

552K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.04B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Ionis Pharmaceuticals Inc Transaction History